Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Arachidonic acid metabolism (mmu00590)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
2310016C
16Rik
KLA  ATP  ATP+KLA
 NM_027127 RIKEN cDNA 2310016C16 gene (2310016C16Rik), mRNA [NM_027127] KLA .94 1.03 1.06 1.07 .99 1.05 .96
ATP .97 1.01 1.01 1.04 1.01 1.07 1.05
KLA/ATP 1.04 1.08 1.09 1.01 1.03 1.02 .98
2810405K
02Rik
KLA  ATP  ATP+KLA
 NM_025582 RIKEN cDNA 2810405K02 gene (2810405K02Rik), mRNA [NM_025582] KLA .77 .68 .61 .70 .71 1.04 1.22
ATP .88 .87 1.16 1.24 1.07 .64 .92
KLA/ATP .65 .74 .89 .88 .88 .58 .54
AK085608
KLA  ATP  ATP+KLA
 AK085608 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630046G10 product:unclassifiable, full insert sequence. [AK085608] KLA .89 .96 1.01 1.03 .96 .98 1.07
ATP 1.03 1.00 .96 1.01 1.05 1.04 1.00
KLA/ATP 1.00 1.00 .99 1.04 1.01 .99 1.00
Alox12
KLA  ATP  ATP+KLA
 NM_007440 arachidonate 12-lipoxygenase (Alox12), mRNA [NM_007440] KLA 1.35 1.36 1.42 1.25 1.25 1.13 1.15
ATP 1.05 1.01 1.03 1.04 1.04 1.42 1.20
KLA/ATP 1.36 1.29 1.23 1.26 1.24 1.31 1.80
Alox12b
KLA  ATP  ATP+KLA
 NM_009659 arachidonate 12-lipoxygenase, 12R type (Alox12b), mRNA [NM_009659] KLA 1.09 1.09 1.18 1.15 1.14 1.28 1.26
ATP .99 .92 1.09 1.07 1.03 1.10 1.29
KLA/ATP 1.16 1.20 1.27 1.30 1.21 1.19 1.30
Alox12e
KLA  ATP  ATP+KLA
 NM_145684 arachidonate lipoxygenase, epidermal (Alox12e), mRNA [NM_145684] KLA .97 .99 1.05 .94 .99 1.01 .96
ATP 1.00 .97 1.01 .98 1.01 1.01 .94
KLA/ATP .99 .92 .91 .98 .95 .95 .95
Alox15
KLA  ATP  ATP+KLA
 NM_009660 arachidonate 15-lipoxygenase (Alox15), mRNA [NM_009660] KLA 1.02 .93 .98 .96 .98 .95 .87
ATP .92 .95 1.09 1.01 .98 1.00 .97
KLA/ATP .97 .95 .98 .94 .98 .97 .92
Alox5
KLA  ATP  ATP+KLA
 NM_009662 arachidonate 5-lipoxygenase (Alox5), mRNA [NM_009662] KLA .83 .87 .88 .87 .71 .58 .21
ATP 1.03 1.03 1.14 1.21 .93 .55 .41
KLA/ATP .86 .85 .90 .97 .84 .61 .24
Alox8
KLA  ATP  ATP+KLA
 NM_009661 arachidonate 8-lipoxygenase (Alox8), mRNA [NM_009661] KLA 1.02 .99 1.01 1.00 .99 1.06 .95
ATP 1.04 .99 .86 .96 .92 1.02 .95
KLA/ATP .98 .99 1.03 1.00 .98 .91 .90
Cbr1
KLA  ATP  ATP+KLA
 U31966 carbonyl reductase (Cbr1) mRNA, complete cds. [U31966] KLA .79 .82 .80 .76 .69 .91 .89
ATP .95 .90 1.24 1.29 1.39 1.58 2.18
KLA/ATP .82 .79 1.22 1.01 1.41 1.76 1.89
Cbr2
KLA  ATP  ATP+KLA
 NM_007621 carbonyl reductase 2 (Cbr2), mRNA [NM_007621] KLA 1.04 1.02 .94 1.08 1.10 1.15 .31
ATP 1.04 .97 1.18 1.27 1.37 1.11 .44
KLA/ATP 1.06 1.09 1.32 1.27 1.33 1.00 .41
Cbr3
KLA  ATP  ATP+KLA
 NM_173047 carbonyl reductase 3 (Cbr3), mRNA [NM_173047] KLA .37 .38 .29 .33 .21 .23 .42
ATP .97 .84 1.07 .78 1.72 6.22 1.28
KLA/ATP .38 .35 .52 .33 1.22 2.51 1.25
Cyp2b10
KLA  ATP  ATP+KLA
 NM_009999 cytochrome P450, family 2, subfamily b, polypeptide 10 (Cyp2b10), transcript variant 2, mRNA [NM_009999] KLA .98 1.03 .97 1.02 1.02 .97 1.03
ATP 1.03 .99 1.02 1.02 .98 1.02 .99
KLA/ATP 1.04 1.00 1.02 .93 .97 .93 .91
Cyp2b13
KLA  ATP  ATP+KLA
 NM_007813 cytochrome P450, family 2, subfamily b, polypeptide 13 (Cyp2b13), mRNA [NM_007813] KLA .99 1.02 1.00 1.06 1.05 1.03 .99
ATP .96 .96 .96 .98 .99 .95 .98
KLA/ATP 1.00 1.03 1.04 1.02 1.01 1.06 .99
Cyp2b19
KLA  ATP  ATP+KLA
 AK029227 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831430P04 product:cytochrome P450, 2b19, full insert sequence. [AK029227] KLA .96 .98 1.02 1.09 1.06 1.00 1.08
ATP 1.02 1.06 .91 1.05 1.00 .97 .95
KLA/ATP .99 .93 .96 1.03 1.00 1.04 1.00
Cyp2b19
KLA  ATP  ATP+KLA
 NM_007814 cytochrome P450, family 2, subfamily b, polypeptide 19 (Cyp2b19), mRNA [NM_007814] KLA 1.14 1.20 1.18 1.17 1.17 1.21 1.14
ATP .96 1.01 1.11 1.08 .99 1.08 1.10
KLA/ATP 1.09 1.05 1.17 1.16 1.16 1.10 1.07
Cyp2b23
KLA  ATP  ATP+KLA
 NM_001081148 cytochrome P450, family 2, subfamily b, polypeptide 23 (Cyp2b23), mRNA [NM_001081148] KLA 1.09 .96 1.01 .95 .97 1.01 .92
ATP .97 1.00 .92 .92 .98 .97 .94
KLA/ATP 1.01 1.02 1.03 .94 .94 .93 .97
Cyp2b9
KLA  ATP  ATP+KLA
 NM_010000 cytochrome P450, family 2, subfamily b, polypeptide 9 (Cyp2b9), mRNA [NM_010000] KLA .99 1.00 1.02 1.01 1.03 .98 1.03
ATP 1.01 .98 .97 .98 1.01 .96 .98
KLA/ATP 1.00 1.04 .94 1.04 1.02 1.03 .99
Cyp2c29
KLA  ATP  ATP+KLA
 NM_007815 cytochrome P450, family 2, subfamily c, polypeptide 29 (Cyp2c29), mRNA [NM_007815] KLA 1.01 .95 1.06 1.12 1.01 1.02 1.12
ATP 1.03 1.02 1.01 1.06 .98 .98 .96
KLA/ATP 1.09 1.14 1.02 .98 .99 .98 .98
Cyp2c37
KLA  ATP  ATP+KLA
 NM_010001 cytochrome P450, family 2. subfamily c, polypeptide 37 (Cyp2c37), mRNA [NM_010001] KLA 1.27 1.43 1.64 1.52 1.65 1.43 1.45
ATP .99 .96 1.03 1.13 1.10 1.03 1.27
KLA/ATP 1.37 1.49 1.22 1.46 1.16 1.12 1.24
Cyp2c38
KLA  ATP  ATP+KLA
 NM_010002 cytochrome P450, family 2, subfamily c, polypeptide 38 (Cyp2c38), mRNA [NM_010002] KLA 1.01 1.06 .98 .96 1.07 .98 .97
ATP 1.01 1.09 1.04 .98 1.00 1.03 .98
KLA/ATP 1.03 .98 1.03 1.04 1.00 1.00 1.01
Cyp2c39
KLA  ATP  ATP+KLA
 NM_010003 cytochrome P450, family 2, subfamily c, polypeptide 39 (Cyp2c39), mRNA [NM_010003] KLA 1.04 1.01 .97 1.00 .99 1.01 .98
ATP 1.04 1.07 .95 1.00 .96 1.03 1.01
KLA/ATP 1.03 1.01 1.02 1.01 1.05 1.05 .99
Cyp2c40
KLA  ATP  ATP+KLA
 NM_010004 cytochrome P450, family 2, subfamily c, polypeptide 40 (Cyp2c40), mRNA [NM_010004] KLA .96 1.06 1.05 1.03 .99 1.01 1.02
ATP .96 1.01 1.02 .97 1.01 1.02 .99
KLA/ATP 1.06 1.03 1.04 .98 1.05 1.01 .97
Cyp2c44
KLA  ATP  ATP+KLA
 NM_001001446 cytochrome P450, family 2, subfamily c, polypeptide 44 (Cyp2c44), mRNA [NM_001001446] KLA .98 1.04 .93 1.05 1.01 .93 .94
ATP 1.02 1.01 1.01 1.04 1.02 1.02 1.00
KLA/ATP .93 .95 1.00 1.05 1.07 1.01 1.01
Cyp2c54
KLA  ATP  ATP+KLA
 NM_206537 cytochrome P450, family 2, subfamily c, polypeptide 54 (Cyp2c54), mRNA [NM_206537] KLA .98 .99 1.04 .97 1.06 1.03 1.04
ATP .99 .98 1.10 1.03 1.03 .98 1.03
KLA/ATP 1.02 1.04 .89 .98 .99 .93 .99
Cyp2c55
KLA  ATP  ATP+KLA
 NM_028089 cytochrome P450, family 2, subfamily c, polypeptide 55 (Cyp2c55), mRNA [NM_028089] KLA .97 1.02 1.01 .99 .99 1.00 .94
ATP 1.04 .98 1.09 .97 1.05 .99 1.06
KLA/ATP 1.04 1.01 1.15 1.03 1.05 1.05 1.09
Cyp2c65
KLA  ATP  ATP+KLA
 AK008688 adult male stomach cDNA, RIKEN full-length enriched library, clone:2210009K14 product:similar to CYTOCHROME P450 2C18 (EC 1.14.14.1) (CYPIIC18) (P450-6B [AK008688] KLA .95 .97 1.02 1.00 .97 1.10 1.04
ATP .98 1.05 1.00 1.10 .98 .99 1.03
KLA/ATP .96 .97 .99 1.01 1.03 1.04 1.03
Cyp2c66
KLA  ATP  ATP+KLA
 NM_001011707 cytochrome P450, family 2, subfamily c, polypeptide 66 (Cyp2c66), mRNA [NM_001011707] KLA 1.03 1.04 .99 1.00 1.06 1.11 1.01
ATP .97 1.01 1.03 1.00 .98 1.03 1.04
KLA/ATP 1.08 .97 1.15 1.02 1.04 1.06 1.08
Cyp2c70
KLA  ATP  ATP+KLA
 NM_145499 cytochrome P450, family 2, subfamily c, polypeptide 70 (Cyp2c70), mRNA [NM_145499] KLA 1.05 .94 .95 .86 1.06 .96 .99
ATP 1.01 .98 .69 .69 .97 .87 1.09
KLA/ATP 1.00 .97 .74 .74 .81 .86 1.17
Cyp2e1
KLA  ATP  ATP+KLA
 NM_021282 cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp2e1), mRNA [NM_021282] KLA .99 1.03 1.05 1.01 .99 1.06 1.00
ATP .96 .93 .98 1.05 1.01 1.03 1.10
KLA/ATP 1.04 .99 1.02 1.00 1.05 1.04 .99
Cyp2j11
KLA  ATP  ATP+KLA
 NM_001004141 cytochrome P450, family 2, subfamily j, polypeptide 11 (Cyp2j11), mRNA [NM_001004141] KLA .95 1.02 1.07 .95 .95 .92 .83
ATP .95 1.02 1.05 .93 .92 .90 1.00
KLA/ATP 1.05 .96 1.00 .97 .90 .82 .86
Cyp2j13
KLA  ATP  ATP+KLA
 NM_145548 cytochrome P450, family 2, subfamily j, polypeptide 13 (Cyp2j13), mRNA [NM_145548] KLA 1.01 .99 .98 1.00 .98 .96 .92
ATP .99 1.03 1.01 .98 .95 1.01 1.02
KLA/ATP .96 1.03 1.02 1.03 .96 .95 .96
Cyp2j5
KLA  ATP  ATP+KLA
 NM_010007 cytochrome P450, family 2, subfamily j, polypeptide 5 (Cyp2j5), mRNA [NM_010007] KLA 1.00 .99 1.05 1.01 1.00 1.06 1.06
ATP .99 1.00 1.03 1.09 1.00 1.03 1.01
KLA/ATP 1.03 .98 1.09 1.11 1.06 1.09 1.01
Cyp2j9
KLA  ATP  ATP+KLA
 NM_028979 cytochrome P450, family 2, subfamily j, polypeptide 9 (Cyp2j9), mRNA [NM_028979] KLA .84 .88 .97 .91 .75 .66 .66
ATP 1.10 .98 .99 .92 .90 .73 .64
KLA/ATP .88 .95 .93 .86 .80 .78 .59
Cyp2u1
KLA  ATP  ATP+KLA
 AK142740 16 days neonate heart cDNA, RIKEN full-length enriched library, clone:D830039I11 product:cytochrome P450, family 2, subfamily u, polypeptide 1, full insert sequence [AK142740] KLA .85 .89 .83 .86 .76 .80 .94
ATP .97 1.09 .99 .90 .84 .87 .96
KLA/ATP .82 .88 .85 .80 .79 .81 .89
Cyp4a10
KLA  ATP  ATP+KLA
 NM_010011 cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10), mRNA [NM_010011] KLA 1.14 1.13 1.13 1.13 1.15 1.12 1.06
ATP 1.02 1.01 1.09 1.03 1.10 1.11 1.00
KLA/ATP 1.09 1.11 1.36 1.23 1.25 1.09 1.02
Cyp4a10
KLA  ATP  ATP+KLA
 X71478 gb|M.musculus Cyp4a-10 mRNA. [X71478] KLA .94 .97 .93 1.01 1.01 1.09 1.26
ATP .96 1.07 1.04 1.18 .88 .77 1.18
KLA/ATP 1.00 .99 .98 .98 .84 .80 1.24
Cyp4a12a
KLA  ATP  ATP+KLA
 NM_177406 cytochrome P450, family 4, subfamily a, polypeptide 12a (Cyp4a12a), mRNA [NM_177406] KLA 1.08 1.04 1.02 1.06 .98 1.05 1.05
ATP .98 1.00 1.10 .99 .96 1.04 .98
KLA/ATP 1.07 1.05 1.11 .96 1.06 1.02 .97
Cyp4a12b
KLA  ATP  ATP+KLA
 NM_172306 cytochrome P450, family 4, subfamily a, polypeptide 12B (Cyp4a12b), mRNA [NM_172306] KLA 1.03 1.05 .95 .99 .94 1.02 1.12
ATP .93 .99 .95 1.00 .93 .95 1.01
KLA/ATP .98 1.01 1.09 1.00 .90 .91 .93
Cyp4a14
KLA  ATP  ATP+KLA
 NM_007822 cytochrome P450, family 4, subfamily a, polypeptide 14 (Cyp4a14), mRNA [NM_007822] KLA .99 1.00 1.00 .97 .96 .97 1.01
ATP .95 .95 .93 .90 .93 .99 1.03
KLA/ATP .97 .99 1.04 .93 .95 .96 .97
Cyp4a29
KLA  ATP  ATP+KLA
 NM_001100183 cytochrome P450, family 4, subfamily a, polypeptide 29 (Cyp4a29), mRNA [NM_001100183] KLA .94 .98 1.04 1.00 .98 1.06 1.03
ATP 1.01 1.02 1.03 1.02 1.01 1.02 .97
KLA/ATP 1.05 1.09 1.03 1.03 .97 1.02 .91
Cyp4a31
KLA  ATP  ATP+KLA
 NM_201640 cytochrome P450, family 4, subfamily a, polypeptide 31 (Cyp4a31), mRNA [NM_201640] KLA 1.14 .99 1.00 .98 1.06 1.03 .96
ATP 1.01 1.05 1.04 .91 .98 .99 .99
KLA/ATP .99 1.03 1.04 .99 .95 .97 1.06
Cyp4f13
KLA  ATP  ATP+KLA
 NM_130882 cytochrome P450, family 4, subfamily f, polypeptide 13 (Cyp4f13), mRNA [NM_130882] KLA .96 .94 1.02 .99 1.11 1.26 1.34
ATP 1.03 1.05 1.03 1.24 .88 .61 .88
KLA/ATP 1.05 1.02 1.01 1.13 .87 .75 1.20
Cyp4f14
KLA  ATP  ATP+KLA
 NM_022434 cytochrome P450, family 4, subfamily f, polypeptide 14 (Cyp4f14), mRNA [NM_022434] KLA 1.06 1.01 1.08 1.04 1.03 1.00 1.05
ATP 1.07 .94 .92 1.01 1.00 .97 1.06
KLA/ATP 1.04 .99 .82 .95 .93 1.05 1.11
Cyp4f15
KLA  ATP  ATP+KLA
 NM_134127 cytochrome P450, family 4, subfamily f, polypeptide 15 (Cyp4f15), mRNA [NM_134127] KLA .98 .95 1.05 1.02 .98 .96 1.05
ATP 1.01 .98 1.09 1.03 1.03 1.02 1.08
KLA/ATP 1.02 .97 .98 .98 .99 1.01 1.02
Cyp4f16
KLA  ATP  ATP+KLA
 NM_024442 cytochrome P450, family 4, subfamily f, polypeptide 16 (Cyp4f16), mRNA [NM_024442] KLA .87 .91 .89 .94 1.01 1.03 1.34
ATP 1.12 1.16 1.07 1.15 .88 .61 1.00
KLA/ATP .95 1.05 .92 .98 .72 .68 1.02
Cyp4f18
KLA  ATP  ATP+KLA
 NM_024444 cytochrome P450, family 4, subfamily f, polypeptide 18 (Cyp4f18), mRNA [NM_024444] KLA 1.03 1.06 1.06 1.15 1.13 1.14 1.29
ATP 1.00 1.06 1.16 1.36 1.36 1.11 1.06
KLA/ATP 1.03 1.11 1.14 1.22 1.20 1.93 2.92
Cyp4f39
KLA  ATP  ATP+KLA
 NM_177307 cytochrome P450, family 4, subfamily f, polypeptide 39 (Cyp4f39), mRNA [NM_177307] KLA .96 1.00 .97 1.06 1.03 1.09 1.07
ATP .99 .95 .93 1.05 .81 .86 1.24
KLA/ATP .97 .88 .84 .91 .89 .96 1.07
Ephx2
KLA  ATP  ATP+KLA
 NM_007940 epoxide hydrolase 2, cytoplasmic (Ephx2), mRNA [NM_007940] KLA 1.03 .96 .96 1.03 1.02 1.03 .87
ATP .97 .95 1.09 1.08 1.00 1.06 .96
KLA/ATP .97 1.03 1.07 1.09 1.13 .98 1.00
Ggt1
KLA  ATP  ATP+KLA
 NM_008116 gamma-glutamyltransferase 1 (Ggt1), mRNA [NM_008116] KLA 1.03 1.00 1.00 1.05 1.00 1.02 1.02
ATP 1.00 1.00 .96 1.00 1.03 1.02 .99
KLA/ATP .98 .99 1.04 1.00 .99 .98 .98
Ggt5
KLA  ATP  ATP+KLA
 NM_011820 gamma-glutamyltransferase 5 (Ggt5), mRNA [NM_011820] KLA .89 .91 .92 .89 .86 .79 .58
ATP 1.00 1.03 .93 .97 .84 .80 .59
KLA/ATP 1.00 .92 .93 .98 .83 .79 .68
Ggt6
KLA  ATP  ATP+KLA
 NM_027819 gamma-glutamyltransferase 6 (Ggt6), mRNA [NM_027819] KLA 1.03 .90 .98 1.07 1.00 1.02 .98
ATP 1.02 1.07 .90 1.02 1.03 1.03 .94
KLA/ATP .99 1.04 .98 .97 1.02 1.01 .96
Ggt7
KLA  ATP  ATP+KLA
 NM_144786 gamma-glutamyltransferase 7 (Ggt7), mRNA [NM_144786] KLA .96 1.03 .97 1.01 1.00 .98 .89
ATP 1.03 1.02 1.01 .92 .94 .97 1.00
KLA/ATP .98 .95 1.05 .89 .92 .94 .94
Gpx1
KLA  ATP  ATP+KLA
 NM_008160 glutathione peroxidase 1 (Gpx1), mRNA [NM_008160] KLA .63 .68 .67 .51 .52 .48 .64
ATP 1.02 1.01 .85 .91 .66 .41 .97
KLA/ATP .76 .73 .47 .61 .45 .39 .70
Gpx2
KLA  ATP  ATP+KLA
 NM_030677 glutathione peroxidase 2 (Gpx2), mRNA [NM_030677] KLA .69 .71 .59 .69 .72 .69 .69
ATP 1.08 1.10 .74 .79 .77 .66 .64
KLA/ATP .70 .65 .69 .74 .78 .76 .53
Gpx3
KLA  ATP  ATP+KLA
 NM_008161 glutathione peroxidase 3 (Gpx3), transcript variant 2, mRNA [NM_008161] KLA 1.14 1.14 1.20 1.09 1.07 .85 .50
ATP 1.15 1.15 1.00 1.84 1.10 .96 .62
KLA/ATP 1.14 1.17 .93 1.48 .90 .99 .64
Gpx5
KLA  ATP  ATP+KLA
 X53780 gb|Mouse mRNA for 24kDa major androgen regulated protein, arMEP24. [X53780] KLA .95 1.02 .99 .99 .97 1.06 .98
ATP 1.04 .94 .96 1.05 1.02 1.01 .98
KLA/ATP .98 1.00 .98 .93 1.00 1.07 .99
Gpx6
KLA  ATP  ATP+KLA
 NM_145451 glutathione peroxidase 6 (Gpx6), mRNA [NM_145451] KLA 1.00 1.05 1.02 .99 1.04 1.03 .94
ATP .98 1.03 1.04 .91 .92 1.03 1.05
KLA/ATP .99 1.01 1.04 .99 .96 .89 1.02
Gpx7
KLA  ATP  ATP+KLA
 NM_024198 glutathione peroxidase 7 (Gpx7), mRNA [NM_024198] KLA .91 1.00 .95 .96 .87 .90 .83
ATP 1.00 1.07 1.06 1.07 .94 .93 .88
KLA/ATP .96 1.01 .95 .98 .82 .90 .86
Hrasls3
KLA  ATP  ATP+KLA
 AK052657 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630015C01 product:H-REV 107 PROTEIN homolog [Rattus norvegicus], full insert sequence. [AK052657] KLA 4.07 4.01 2.57 2.26 1.94 1.66 1.10
ATP .93 .92 1.00 .96 .95 .99 1.08
KLA/ATP 3.36 2.63 1.76 1.26 1.41 1.22 1.27
Hrasls3
KLA  ATP  ATP+KLA
 NM_139269 HRAS like suppressor 3 (Hrasls3), mRNA [NM_139269] KLA 11.37 10.85 12.50 16.13 13.98 17.12 6.64
ATP .86 .78 .96 .89 .84 .99 1.03
KLA/ATP 8.90 10.50 15.81 13.10 11.95 11.16 10.19
Lta4h
KLA  ATP  ATP+KLA
 NM_008517 leukotriene A4 hydrolase (Lta4h), mRNA [NM_008517] KLA .84 .85 .77 .59 .48 .46 .63
ATP .99 1.20 1.11 1.29 1.02 .98 .83
KLA/ATP .86 .85 .72 .95 .72 .92 .59
Ltc4s
KLA  ATP  ATP+KLA
 NM_008521 leukotriene C4 synthase (Ltc4s), mRNA [NM_008521] KLA .96 .97 .92 .83 .62 .43 .13
ATP .94 .98 .97 1.09 .77 .51 .27
KLA/ATP .92 .89 .88 .81 .68 .49 .26
Mm.1332
KLA  ATP  ATP+KLA
 171543845 Unknown KLA .95 .97 .87 .99 .98 .98 1.04
ATP 1.00 .93 1.00 1.08 .95 1.02 .92
KLA/ATP 1.03 1.12 .94 .98 1.01 .91 1.10
Mm.16006
7
KLA  ATP  ATP+KLA
 124487226 Unknown KLA .90 .88 .87 .85 .80 .85 .64
ATP .95 .95 1.00 .94 1.00 .91 .67
KLA/ATP .89 .86 .93 .82 .85 .84 .63
Mm.26915
KLA  ATP  ATP+KLA
 51921286 Unknown KLA 1.02 1.03 .96 1.11 1.05 .96 .96
ATP 1.02 1.00 .98 1.06 1.04 .99 1.08
KLA/ATP .96 .94 1.06 1.00 1.02 1.00 1.03
Mm.26940
KLA  ATP  ATP+KLA
 113680351 Unknown KLA .71 .71 .72 .65 .63 .83 .93
ATP .94 .87 1.23 1.30 1.21 1.41 1.76
KLA/ATP .70 .69 .89 .88 1.21 1.51 1.45
Mm.28967
2
KLA  ATP  ATP+KLA
 133893229 Unknown KLA 1.01 1.03 1.00 .97 .97 1.02 1.02
ATP .97 .98 .92 1.05 .98 .99 1.07
KLA/ATP .93 1.03 .95 .99 1.02 1.04 1.05
Mm.29467
8
KLA  ATP  ATP+KLA
 124487254 Unknown KLA 1.01 1.07 1.03 .98 1.02 1.09 1.02
ATP 1.02 1.00 1.02 1.08 .96 1.04 .97
KLA/ATP 1.01 1.00 1.05 1.05 1.01 1.06 1.01
Mm.33050
7
KLA  ATP  ATP+KLA
 67906182 Unknown KLA .94 .98 .99 1.03 1.05 1.07 .98
ATP .95 1.02 .97 .98 .99 1.05 1.02
KLA/ATP 1.02 1.05 1.01 1.03 .99 .98 .97
Mm.42607
7
KLA  ATP  ATP+KLA
 58743309 Unknown KLA .98 .93 1.04 1.03 .97 .98 1.16
ATP 1.02 .95 1.02 1.06 .96 .95 1.04
KLA/ATP .98 .97 .98 1.01 .99 1.11 .91
Mm.44829
2
KLA  ATP  ATP+KLA
 86198313 Unknown KLA 1.12 1.03 1.02 1.14 1.04 1.07 1.02
ATP .95 .98 1.18 1.06 1.12 1.07 1.04
KLA/ATP 1.04 1.15 1.29 1.11 1.16 1.21 1.14
Mm.46661
0
KLA  ATP  ATP+KLA
 82894546 Unknown KLA .86 .90 .99 .94 1.02 .83 .91
ATP 1.10 1.04 1.04 1.15 1.03 .93 .84
KLA/ATP .86 .85 1.00 1.10 .94 .85 .90
Mm.71913
KLA  ATP  ATP+KLA
 118130231 Unknown KLA .93 1.00 1.06 .97 .95 .98 1.04
ATP 1.00 .98 1.08 1.02 .92 .90 .99
KLA/ATP .99 1.01 1.00 .99 .99 .99 1.01
Pla2g10
KLA  ATP  ATP+KLA
 NM_011987 phospholipase A2, group X (Pla2g10), mRNA [NM_011987] KLA .99 1.11 1.02 .99 1.00 1.01 1.02
ATP 1.02 .97 1.01 1.03 1.00 1.02 1.04
KLA/ATP 1.04 .96 .95 1.04 1.06 1.05 1.01
Pla2g12a
KLA  ATP  ATP+KLA
 NM_023196 phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196] KLA 1.03 1.06 .97 1.00 .78 .75 .92
ATP .91 .99 1.29 1.30 1.20 1.48 1.71
KLA/ATP .92 .99 1.19 1.16 1.06 1.12 1.36
Pla2g12a
KLA  ATP  ATP+KLA
 NM_183423 phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423] KLA .90 1.00 .87 .95 .76 .68 .88
ATP .96 .94 1.26 1.24 1.19 1.47 1.88
KLA/ATP .89 .90 1.08 1.07 1.06 1.02 1.59
Pla2g12b
KLA  ATP  ATP+KLA
 NM_023530 phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530] KLA .98 .95 1.05 .99 1.03 .99 .94
ATP 1.02 1.04 1.07 1.05 .92 1.04 1.00
KLA/ATP .98 .92 1.10 1.11 1.09 1.03 1.04
Pla2g1b
KLA  ATP  ATP+KLA
 NM_011107 phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] KLA 1.00 1.01 1.01 1.11 1.00 1.28 1.00
ATP .98 1.03 1.09 1.03 1.01 1.02 1.04
KLA/ATP .93 .94 1.01 1.00 .94 1.09 1.07
Pla2g2a
KLA  ATP  ATP+KLA
 NM_001082531 phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531] KLA 1.08 .99 1.00 1.06 .98 1.01 .94
ATP 1.07 .98 1.04 1.06 .90 .98 .98
KLA/ATP .98 1.03 1.00 1.04 .94 .97 .96
Pla2g2c
KLA  ATP  ATP+KLA
 NM_008868 phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868] KLA .98 .99 1.05 .98 1.01 1.00 1.04
ATP 1.08 1.06 1.09 .93 .92 .92 1.00
KLA/ATP 1.03 1.04 1.02 1.04 .98 1.01 1.02
Pla2g2d
KLA  ATP  ATP+KLA
 NM_011109 phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109] KLA 1.02 1.02 .99 .99 1.00 1.01 1.00
ATP .95 1.11 1.10 1.11 .98 .99 1.12
KLA/ATP 1.02 1.00 1.19 1.11 1.00 .96 1.01
Pla2g2e
KLA  ATP  ATP+KLA
 NM_012044 phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044] KLA .78 .75 .74 .72 .62 .69 1.40
ATP 1.06 1.00 .92 1.04 .83 .76 3.74
KLA/ATP .78 .80 .69 .74 .70 .74 2.24
Pla2g2f
KLA  ATP  ATP+KLA
 NM_012045 phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045] KLA 1.02 .99 1.03 1.01 1.00 .95 .99
ATP 1.01 1.06 1.11 .97 1.09 1.11 .99
KLA/ATP 1.10 1.05 1.04 .95 1.04 1.01 .96
Pla2g3
KLA  ATP  ATP+KLA
 NM_172791 phospholipase A2, group III (Pla2g3), mRNA [NM_172791] KLA 1.04 1.05 1.02 1.01 1.04 1.11 1.00
ATP .96 .97 1.10 .91 .99 .97 1.08
KLA/ATP 1.03 1.11 1.10 .98 .95 .98 1.07
Pla2g4a
KLA  ATP  ATP+KLA
 NM_008869 phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869] KLA 3.93 4.49 4.86 6.40 6.44 3.10 1.68
ATP 1.13 1.36 1.27 1.30 1.02 5.37 1.47
KLA/ATP 3.64 4.45 4.76 7.11 2.96 4.08 2.60
Pla2g4b
KLA  ATP  ATP+KLA
 NM_145378 phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378] KLA 1.09 1.18 .95 1.01 .97 .97 .77
ATP 1.05 1.14 1.28 .94 .88 1.18 .70
KLA/ATP 1.23 1.43 1.21 1.02 1.15 1.16 .78
Pla2g4c
KLA  ATP  ATP+KLA
 AK145339 1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339] KLA 1.09 1.21 1.33 1.17 1.26 1.30 1.05
ATP .97 1.06 1.00 .98 .98 .98 1.05
KLA/ATP 1.19 1.16 1.18 1.13 1.04 1.02 1.06
Pla2g4c
KLA  ATP  ATP+KLA
 NM_001004762 phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762] KLA .93 1.00 .94 .93 .94 .94 .96
ATP .98 .96 1.13 .97 .99 .89 .96
KLA/ATP 1.01 1.01 1.07 1.01 .94 1.01 .92
Pla2g4e
KLA  ATP  ATP+KLA
 AK049063 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063] KLA 1.03 1.09 1.01 1.01 1.06 .94 1.05
ATP 1.03 1.00 1.06 1.01 .96 1.05 1.05
KLA/ATP .98 1.00 1.01 .98 1.03 .95 1.01
Pla2g4e
KLA  ATP  ATP+KLA
 NM_177845 phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845] KLA .97 .95 1.01 .97 1.02 1.03 1.05
ATP .98 .99 1.00 1.10 .98 1.00 1.02
KLA/ATP 1.05 .93 .96 1.03 1.08 1.05 .99
Pla2g4f
KLA  ATP  ATP+KLA
 NM_001024145 phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145] KLA 1.08 .99 1.04 1.02 1.04 .98 1.01
ATP .99 1.04 .99 1.03 1.12 1.01 1.25
KLA/ATP .97 1.04 1.10 1.06 1.04 1.03 1.03
Pla2g5
KLA  ATP  ATP+KLA
 NM_011110 phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110] KLA .65 .62 .56 .53 .62 1.60 3.01
ATP .90 .82 .88 1.69 1.82 1.26 6.32
KLA/ATP .63 .59 .65 .63 .91 1.56 5.59
Pla2g6
KLA  ATP  ATP+KLA
 NM_016915 phospholipase A2, group VI (Pla2g6), mRNA [NM_016915] KLA .60 .59 .56 .60 .94 1.31 1.59
ATP 1.10 1.14 .95 1.05 1.06 1.13 1.14
KLA/ATP .63 .56 .54 .56 .71 .97 1.55
Plb1
KLA  ATP  ATP+KLA
 AK015993 adult male testis cDNA, RIKEN full-length enriched library, clone:4930539A06 product:weakly similar to PHOSPHOLIPASE B [Rattus norvegicus], full insert sequence. [AK015993] KLA .99 .99 1.05 1.02 1.03 1.07 1.02
ATP 1.04 1.03 1.07 1.06 1.09 1.01 1.02
KLA/ATP 1.07 1.00 .96 1.09 1.05 1.08 1.01
Plb1
KLA  ATP  ATP+KLA
 AK087596 2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230021C09 product:hypothetical protein, full insert sequence. [AK087596] KLA .93 .99 .99 1.07 .98 1.00 .98
ATP 1.08 1.00 .97 1.07 1.04 1.09 .96
KLA/ATP 1.06 .96 1.00 .98 1.04 1.06 .98
Plb1
KLA  ATP  ATP+KLA
 NM_001081407 phospholipase B1 (Plb1), mRNA [NM_001081407] KLA 1.05 1.09 1.05 1.04 1.05 1.03 .85
ATP .96 1.03 1.02 .95 1.06 1.01 .92
KLA/ATP 1.00 1.00 1.09 1.00 .97 .99 .86
Ptgds
KLA  ATP  ATP+KLA
 NM_008963 prostaglandin D2 synthase (brain) (Ptgds), mRNA [NM_008963] KLA 1.19 1.16 1.11 1.19 1.04 .98 .93
ATP .99 .99 1.10 1.07 1.02 1.00 .97
KLA/ATP 1.18 1.18 1.31 1.39 1.09 .89 .90
Ptgds2
KLA  ATP  ATP+KLA
 NM_019455 prostaglandin D2 synthase 2, hematopoietic (Ptgds2), mRNA [NM_019455] KLA .50 .48 .58 .52 .66 .57 .53
ATP 1.03 1.05 1.05 1.36 1.04 .32 .61
KLA/ATP .52 .47 .50 .74 .73 .35 .42
Ptges
KLA  ATP  ATP+KLA
 NM_022415 prostaglandin E synthase (Ptges), mRNA [NM_022415] KLA 16.01 15.00 16.36 20.05 28.20 32.79 23.08
ATP 1.00 1.03 1.44 2.27 10.67 30.61 17.52
KLA/ATP 14.56 16.98 20.33 21.07 21.87 25.39 38.01
Ptges2
KLA  ATP  ATP+KLA
 NM_133783 prostaglandin E synthase 2 (Ptges2), mRNA [NM_133783] KLA 1.02 1.07 1.30 1.30 1.39 1.06 1.43
ATP 1.09 1.14 .97 1.09 .70 1.00 1.20
KLA/ATP 1.19 1.12 .93 1.13 .81 .97 1.37
Ptges3
KLA  ATP  ATP+KLA
 NM_019766 prostaglandin E synthase 3 (cytosolic) (Ptges3), mRNA [NM_019766] KLA 1.26 1.26 1.19 1.10 1.10 1.01 1.20
ATP 1.08 1.21 1.14 1.68 1.49 1.49 .65
KLA/ATP 1.31 1.49 1.19 1.74 1.34 1.12 .78
Ptgis
KLA  ATP  ATP+KLA
 NM_008968 prostaglandin I2 (prostacyclin) synthase (Ptgis), mRNA [NM_008968] KLA 1.05 1.07 .93 1.05 1.05 1.05 1.02
ATP 1.01 .98 1.01 1.04 1.02 .92 1.00
KLA/ATP 1.09 .99 .94 .99 .96 1.01 1.06
Ptgs1
KLA  ATP  ATP+KLA
 NM_008969 prostaglandin-endoperoxide synthase 1 (Ptgs1), mRNA [NM_008969] KLA .74 .74 .76 .74 .61 .53 .18
ATP 1.01 1.05 1.29 1.14 .99 1.16 3.96
KLA/ATP .77 .71 .88 .77 .75 .61 .40
Ptgs2
KLA  ATP  ATP+KLA
 NM_011198 prostaglandin-endoperoxide synthase 2 (Ptgs2), mRNA [NM_011198] KLA 181.04 220.88 218.58 132.79 103.05 22.69 18.02
ATP 2.47 9.45 52.13 208.62 271.22 306.11 6.86
KLA/ATP 233.39 387.29 617.86 ###.## 608.44 290.80 112.22
Tbxas1
KLA  ATP  ATP+KLA
 AK048544 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130072B09 product:thromboxane A synthase 1, platelet, full insert sequence. [AK048544] KLA .96 .96 1.09 1.03 .96 1.02 .96
ATP 1.02 .96 .99 .97 .94 .95 1.51
KLA/ATP .97 .97 .95 .95 .92 .96 1.30
Tbxas1
KLA  ATP  ATP+KLA
 NM_011539 thromboxane A synthase 1, platelet (Tbxas1), mRNA [NM_011539] KLA .62 .62 .66 .58 .64 .76 .74
ATP 1.12 1.08 .92 .94 .74 .42 .68
KLA/ATP .69 .73 .61 .62 .42 .33 .51